I70.563
Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, bilateral legs
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code I70.563 refers to a serious condition where atherosclerosis, a buildup of fatty deposits, affects biological bypass grafts in the legs, leading to gangrene in both limbs. This condition occurs when blood flow is severely reduced or blocked due to narrowing or hardening of the arteries, causing tissue death. It typically affects individuals with advanced vascular disease and can result in significant health complications if not managed appropriately.
Causes & Symptoms
Clinical Causes: Progressive atherosclerosis leading to artery narrowing and hardening Formation of plaque within the biological grafts used in leg bypass surgeries Chronic vascular risk factors such as smoking, high blood pressure, and high cholesterol levels Diabetes mellitus, which accelerates arterial damage Previous surgical intervention involving biological grafts that can develop complications over time Infections or trauma affecting the graft site Legal or unnatural factors contributing to graft deterioration
Key Symptoms: Severe pain and tenderness in the legs Discoloration of the skin, often darkening or turning black Swelling and coldness in the affected limbs Presence of ulcers or open sores that do not heal Signs of tissue death, including gangrene Weak or absent pulses in the legs and feet Numbness or tingling sensations Fainting or dizziness in severe cases due to compromised circulation
Diagnostic & Treatment
Diagnosis Path: The diagnosis involves a combination of medical history, physical examination, and diagnostic tests such as Doppler ultrasound, angiography, or other imaging techniques. These tools help visualize blood flow through the grafts, identify blockages or narrowing, and assess tissue viability. Blood tests may also be performed to check for underlying risk factors like high cholesterol or diabetes. The definitive diagnosis closely examines the grafts' condition and the extent of tissue damage or gangrene.
Treatment Protocols: Managing this condition aims to restore blood flow, prevent further tissue loss, and address underlying risk factors. Treatment options may include: - Medical therapy such as antiplatelet agents, statins, and other medications to reduce plaque buildup and improve circulation - Surgical procedures like graft revision, bypass, or removal of the damaged graft - Debridement or amputation of necrotic tissue in severe cases of gangrene - Lifestyle modifications including smoking cessation, dietary changes, and exercise programs - Managing comorbidities such as diabetes, hypertension, and hyperlipidemia An interdisciplinary approach involving vascular surgery, cardiology, and wound care specialists is often necessary for optimal outcomes.
Clinical Advice & FAQs
Billing Guidance
Is I70.563 a billable ICD-10 code?
Yes, I70.563 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report I70.563?
Clinical documentation must specify the nature of Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, bilateral legs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference